Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0000895345-23-000391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-16 | 2023-06-14 | CLOV | Martin Joseph Richards | GC | F - Tax | $0.94 | -98.8K | 2.72M | -4% | -$92.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-06-14 | F | D | 98,827 | $0.94 | 2,718,857 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 15, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date. |